Exploratory Centers for Translational Research on the Clinical Neurobiology of Drug Addiction (P20)
The summary for the Exploratory Centers for Translational Research on the Clinical Neurobiology of Drug Addiction (P20) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Exploratory Centers for Translational Research on the Clinical Neurobiology of Drug Addiction (P20): -This solicitation invites applications for the development of Exploratory Translational Research Centers on the clinical neurobiology of drug abuse and addiction. For purposes of this RFA, an Exploratory Translational Research Center is defined as an entity with a strong primary human neurobiology focus in which preclinical research is included to directly inform or provide a mechanistic foundation for the human neuroscience/neurobiologic research. -NIDA intends to commit $2.5 million dollars in FY2008 to fund 2-3 new grants in response to this RFA. Applicants may request support for only one period of up to four years; direct costs requested may not exceed $600,000 in any one year. -This RFA will use the NIH P20 award mechanism. The P20 is a planning grant mechanism to promote the development of mature translational research centers by the end of the funding period. The focus of these applications should be on the development of appropriate infrastructure, including personnel and resources, and the generation of sufficient high quality data to provide the basis for a mature P50 translational research center application by the end of the funding period.
Federal Grant Title: | Exploratory Centers for Translational Research on the Clinical Neurobiology of Drug Addiction (P20) |
Federal Agency Name: | National Institutes of Health |
Grant Categories: | Health Education |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | RFA-DA-08-022 |
Type of Funding: | Grant |
CFDA Numbers: | 93.279 |
CFDA Descriptions: | Drug Abuse and Addiction Research Programs |
Current Application Deadline: | No deadline provided |
Original Application Deadline: | Feb 27, 2008 |
Posted Date: | Dec 10, 2007 |
Creation Date: | Dec 12, 2007 |
Archive Date: | Apr 13, 2008 |
Total Program Funding: | $2,500,000 |
Maximum Federal Grant Award: | |
Minimum Federal Grant Award: | |
Expected Number of Awards: | |
Cost Sharing or Matching: | No |
- Applicants Eligible for this Grant
- Others (see text field entitled "Additional Information on Eligibility" for clarification) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Special district governments Native American tribal governments (Federally recognized) Private institutions of higher education Independent school districts Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education County governments Native American tribal organizations (other than Federally recognized tribal governments) Public and State controlled institutions of higher education City or township governments Public housing authorities/Indian housing authorities
- Additional Information on Eligibility
- Foreign institutions are eligible to apply. Eligible agencies of the Federal Government can apply. Faith-based or community-based organizations can apply.
- Link to Full Grant Announcement
- Information not provided
- Grant Announcement Contact
- NIH OER Webmaster
[email protected]
[email protected] If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster - Similar Government Grants
- • Research on the Neuro-Immune Axis in the context of HIV and Substance Use (R01 Clinical Tr...
- • Research on the Neuro-Immune Axis in the Context of HIV and Substance Use (R21 Clinical Tr...
- • Developing Digital Therapeutics for Substance Use Disorders (UG3/UH3 Clinical Trial option...
- • Transformative Research on the Basic Mechanisms of Polysubstance use in Addiction (R01 - C...
- • Mechanistic Studies on Social Behavior in Substance Use Disorder (R01 Clinical Trials Not ...
- • NIDA Phase II Small Business Innovation Research (SBIR [R44]) Competing Renewal Awards
- • Drug Abuse Aspects of Hiv/Aids and Other Infections
- • Epidemiology of Drug Abuse
- More Grants from the National Institutes of Health
- • HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allow...
- • Technologies and Assays for Therapeutic Genome Editing INDs (U01, Clinical Trial Not Allow...
- • Developmental AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optio...
- • AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional)
- • NIH Directors Pioneer Award Program (DP1 Clinical Trial Optional)